Predictors of premature discontinuation of treatment in multiple disease states | Zendy

Eric Nantz | Zendy; Hong LiuSeifert | Zendy; Skljarevski | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Predictors of premature discontinuation of treatment in multiple disease states

Author(s) -

Eric Nantz,

Hong LiuSeifert,

Skljarevski

Publication year - 2009

Publication title -

patient preference and adherence

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.885

H-Index - 48

ISSN - 1177-889X

DOI - 10.2147/ppa.s4633

Subject(s) - discontinuation , medicine , adverse effect , fibromyalgia , anxiety , disease , clinical trial , depression (economics) , placebo , intensive care medicine , psychiatry , alternative medicine , pathology , economics , macroeconomics

Premature discontinuation of treatment impacts outcomes of clinical practice. The traditional perception has been patient discontinuation is mainly driven by unwanted side effects. Systematic analysis of data from clinical trials across several disease states was performed to identify predictors of premature discontinuation during clinical interventions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research